Meningiomas are the most common intracranial tumor, making up more than a third of all
primary central nervous system (CNS) tumors. They are mostly benign tumors that can be …

Background There remains uncertainty about the impact of menopausal hormone therapy
(MHT) on women's health. A systematic, comprehensive assessment of the effects on …

Abstract Background The American Cancer Society, Centers for Disease Control and
Prevention, National Cancer Institute, and North American Association of Central Cancer …

Brain and central nervous system (CNS) tumors represent approximately 1% of all newly
diagnosed cancers in the United States, and about 2% of cancer deaths. 1, 2 These are a …

Rapid advance in oncology leads to increasing survival of oncologic patients. More and
more of them live long enough to reach either the natural age of menopause or, as a side …

Meningiomas are common intracranial tumors with a female predominance. Their etiology is
still poorly documented. The role of sexual hormones has long been evoked, and data have …

Objective: Whether adiposity and lack of physical activity affect the risk for developing
meningioma and glioma is poorly understood. Our objective was to characterize these …

Background The progesterone receptor (PR) is variably expressed in most meningiomas
and was found to have prognostic significance. However, the correlation with patient age …

Female sex hormones are thought to affect women's risk of developing central nervous
system (CNS) tumors. Some have reported an increased risk in users of menopausal …

Background The relationship between meningiomas and exogenous sex hormones is well
known, but cyproterone acetate (CA), a progesterone agonist, seems to have a stronger …